Key result
CYP-450 inhibition significantly decreased mean arterial blood pressure only in low-sodium (-9%) and high-sodium (-22%) rats pre-treated with l-NAME, correlating with dietary sodium (P<0.001).
p-value: p=<0.001
In rats, the role of CYP-450-dependent agents in controlling blood pressure and kidney function becomes crucial under conditions of high sodium intake or after NOS inhibition.
Sodium-dependent CYP-450 effects on blood pressure in nitric oxide deficiency models; leaves open translational relevance to human hypertension.
AIM: Interaction was examined of nitric oxide (NO) and cytochrome P-450 (CYP-450)-dependent arachidonic acid derivatives, 20-HETE and EETs, in control of arterial pressure (MABP) and renal function. Modification of this interaction by changing sodium intake was also studied. METHODS: On low, standard or high Na diet (LS, STD and HS rats respectively) effects of sequential blockade of NO synthases (NOS) and CYP-450 enzyme activity on MABP, renal blood flow (RBF, Transonic probe), renal medullary perfusion (MBF, laser-Doppler technique), medullary tissue NO (selective electrode) and renal excretion were examined in anaesthetized rats. All NOS were blocked with N(ϖ) -nitro-l-arginine methyl ester (l-NAME), the neuronal NOS with S-methyl-l-thiocitrulline (SMTC), and CYP-450 with 1-aminobenzotriazole (ABT). RESULTS: In each diet group the baseline MABP was highest in rats pre-treated with l-NAME. CYP-450 inhibition significantly decreased MABP only in LS (-9%) and HS rats (-22%) pre-treated with l-NAME. This MABP decrease correlated directly with the dietary sodium content (r = 0.644, P < 0.001). CYP-450 inhibition decreased RBF in LS and HS rats (not in HS pre-treated with l-NAME). Acute exclusion of CYP-450 significantly increased MBF only in STD, SMTC pre-treated rats; in HS group it significantly increased medullary tissue NO by about 1.0 nA. The post-ABT changes in renal excretion occurred in LS and HS rats, irrespective of the status of NO synthesis. CONCLUSIONS: Both NO- and CYP-450-dependent agents contribute to blood pressure and kidney function control, however, the role of 20-HETE and EETs becomes crucial only under conditions of high sodium intake or after NOS inhibition.
No takes yet. Share an insight, caveat, or question.
Kuczeriszka et al. (2010) studied Blood pressure and renal function. Sequential blockade of NO synthases (NOS) and CYP-450 enzyme activity vs. Baseline / varying sodium diets was evaluated on Mean arterial blood pressure (MABP) and renal function (p=<0.001). CYP-450 inhibition significantly decreased mean arterial blood pressure only in low-sodium (-9%) and high-sodium (-22%) rats pre-treated with l-NAME, correlating with dietary sodium (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: